Basking Biosciences
PrivateLast Round
Seed Round
Apr 2, 2026
Total Funding Raised
$60.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Basking Biosciences is a clinical-stage biopharmaceutical company developing a novel, reversible thrombolytic therapy designed to treat acute ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Basking Biosciences Comparables
Compare Basking Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmazz, Inc. | 79% | |
| Aronora, Inc. | 79% | |
| Silver Creek Pharmaceuticals | 75% |
Basking Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 2, 2026 | ||||
| Series A | Jan 30, 2024 | ||||
| Seed | Dec 7, 2020 |
Key People
Founding team and executive leadership
Basking Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio State University | Series A |
| ARCH Venture Partners | Series A |
| Viva BioInnovator | Seed |
| ARCH Venture Partners | Series A |
| Rev1 Ventures | Series A, Seed |
| RTW Investments | Series A |
| Platanus Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 180% MoM, reaching 1.2K.
- Jun 1, 2026
Grew 27% QoQ, from 15 to 19 employees.
Recent news
Latest coverage and updates
- is_developingJul 30, 2026
Basking Biosciences, Inc. is developing reversible thrombolytic therapy for acute ischemic stroke on Jul 30th '26.
Basking Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Basking Biosciences's valuation, stock price, and market status.
Is Basking Biosciences a public or private company?
Basking Biosciences is a private company.
What is the current stock price of Basking Biosciences?
Basking Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Basking Biosciences worth (valuation)?
Valuation information for Basking Biosciences is not publicly available.
Can I buy Basking Biosciences stock?
Basking Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Basking Biosciences's last funding round?
Basking Biosciences's most recent funding round was Seed Round on April 2, 2026.
Who are the main investors in Basking Biosciences?
Key investors in Basking Biosciences include Viva BioInnovator, ARCH Venture Partners, Broadview Ventures.
Will Basking Biosciences IPO soon?
No public IPO plans have been announced for Basking Biosciences.
How can I track Basking Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Basking Biosciences's secondary market activity and sign up for updates.